VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential to treat anxiety, depression, and other central nervous system (CNS) disorders. The company is headquartered in South San Francisco, California. Show more

343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080, South San Francisco, CA, 94080, USA

https://www.vistagen.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

11.22M

52 Wk Range

$0.20 - $5.14

Previous Close

$0.26

Open

$0.26

Volume

449,671

Day Range

$0.25 - $0.26

Enterprise Value

-19.54M

Cash

16.99M

Avg Qtr Burn

-14.71M

Insider Ownership

0.37%

Institutional Own.

31.05%

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Fasedienol (PH94B) Details Social Anxiety Disorder	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Itruvone, PH10 (pherine nasal spray ) Details Major depressive disorder	Phase 2b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PH284 (nasal spray) Details Cancer cachexia	Phase 2a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PH15 (pherine nasal spray) Details Cognitive Dysfunction	Phase 2a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AV-101(4-Cl-KYN) (targets the NMDAR) Details Major depressive disorder	Phase 2a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Fasedienol (PH94B) (pherine nasal spray) Details Adjustment Disorder	Phase 2a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PH80 (nasal spray) Details Menopause, Hot flashes	IND Acceptance decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.